Clinical Trials Logo

Filter by:
NCT ID: NCT03583827 Recruiting - Stroke Clinical Trials

Motor Learning of Stroke Patients in Virtual Environments

Start date: February 10, 2014
Phase: N/A
Study type: Interventional

The aim of this study is to assess the motor learning of patients with chronic stroke in virtual environments. Half the patients will undergo conventional therapy and half virtual reality training using virtual game. The study will also include healthy individuals matched for age, sex, schooling and hand laterality.

NCT ID: NCT03583164 Recruiting - Clinical trials for Invasive Fungal Infections

Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options

FORMULA-OLS
Start date: June 6, 2018
Phase: Phase 2
Study type: Interventional

A study to evaluate F901318 (study drug) for the treatment of invasive fungal infections in patients lacking suitable alternative treatment options.

NCT ID: NCT03577860 Recruiting - Clinical trials for Brachial Plexus Block

Ventilation and Pulmonary Aeration, Electrical Impedance Tomography, Interscalene Brachial Plexus Block

Start date: May 17, 2018
Phase: N/A
Study type: Interventional

Patients with indication of shoulder surgery will be submitted to ultrasound-guided interscalene brachial plexus block with 4ml or 15ml of bupivacaine- epinephrine 0,5%- 1:200,000 at level of C5-6 roots and will be evaluated their ventilation and pulmonary aeration by electrical impedance tomography

NCT ID: NCT03576339 Recruiting - Palatal Wound Clinical Trials

Influence of Electrical Stimulation on Palatal Wound Healing.

Start date: April 2, 2018
Phase: N/A
Study type: Interventional

The aim of this present study is to evaluate the clinical and patients-centered parameters of electric stimulation on wound healing process of the donor palatal area after free gingival graft (FGG) removal.

NCT ID: NCT03574571 Recruiting - Prostate Cancer Clinical Trials

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Start date: June 19, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.

NCT ID: NCT03574103 Recruiting - Clinical trials for Overweight and Obesity

Chronic Effect of Fasting

Start date: July 9, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to determine if time-restricted feeding (TRF) is an effective dietary strategy to weight loss after 8 weeks intervention. TRF will be compared with an intervention without restriction in time for feeding. Both strategies will be with caloric restriction.

NCT ID: NCT03573089 Recruiting - Clinical trials for Kidney Failure, Chronic

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

PHOSPHATE
Start date: December 10, 2019
Phase: N/A
Study type: Interventional

During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate levels on important patient-centred outcomes has never been tested. This trial will evaluate whether compared to high levels, lowering blood phosphate levels would reduce death or major events due to heart disease, improve physical health, and be cost-effective.

NCT ID: NCT03571568 Recruiting - Clinical trials for Indolent B-Cell Non-Hodgkin Lymphoma

A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma

Start date: May 16, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcyRIIB), in Combination with Rituximab in Subjects with Indolent B-Cell Non-Hodgkin Lymphoma That has Relapsed or is Refractory to Rituximab

NCT ID: NCT03569540 Recruiting - Clinical trials for Subarachnoid Hemorrhage, Aneurysmal

Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage

GASH
Start date: July 3, 2018
Phase: Phase 4
Study type: Interventional

A randomized, double-blind and prospective trial meant to evaluate the use of Glibenclamide on acute aneurysmatic subarachnoid hemorrhage. Patients will allocated randomly in two groups, one for 05 mg daily intake of glibenclamide for 21 days and another for control with placebo. General clinical data and late cognitive status will be accessed in both groups.

NCT ID: NCT03568383 Recruiting - Tuberculosis, MDR Clinical Trials

Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients

PHOENIx MDR-TB
Start date: June 3, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing confirmed or probable active tuberculosis (TB) during 96 weeks of follow-up among high-risk household contacts (HHCs) of adults with multidrug-resistant tuberculosis (MDR-TB) (index cases). High-risk HHCs are those with HIV or non-HIV immunosuppression, latent TB infection, and young children below the age of 5 years.